FAF. M. Aslinia

F. M. Aslinia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


F. M. Aslinia has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • A. L. Mindikoglu

    Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    1 shared publication
  • B. Philosophe

    Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA

    1 shared publication
  • C. D. Howell

    Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    1 shared publication
  • C. Drachenberg

    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA

    1 shared publication
  • O. A. Adeyemo

    Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    1 shared publication
  • Sharmeel K. Wasan

    Section of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, USA

    1 shared publication

Latest Publications

  • End‐stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection

    by F. M. Aslinia, S. K. Wasan, A. L. Mindikoglu, O. A. Adeyemo, B. Philosophe, C. Drachenberg, C. D. Howell

    Summary.  Recipients of haemodialysis for end‐stage renal disease (ESRD) have a higher prevalence of hepatitis C virus (HCV) infection relative to the general US population. However, the natural course of HCV infection in patients with renal failure, including African Americans (AAs) and Caucasian Americans (CAs), is not well known. We compared the degree of liver inflammation and fibrosis in AA and CA patients with HCV infection, with and without ESRD. This was a cross‐sectional study of 156 HCV patients with ESRD (130 AAs and 26 CAs) with a liver biopsy between 1992 and 2005. The control group consisted of 138 patients (50 AAs; 88 CAs) with HCV infections and a serum creatinine P < 0.0001) and less hepatic necro‐inflammation (Knodell histological activity index ‐I, II and III; P < 0.05) and fibrosis (Knodell histological activity index ‐IV; P < 0.0001). There were no racial differences in serum liver chemistry and histology scores among patients with renal failure. In a multivariate analysis, younger age, ESRD, AA race and a lower serum alkaline phosphatase were associated with lower odds for advanced liver fibrosis. Thus, HCV patients with ESRD had a lower degree of hepatic inflammation and fibrosis compared to those without renal disease, independent of race.